Effect of direct access to physiotherapy on prescribing and imaging in primary care for musculoskeletal disorders: a systematic review and meta-analysis
Family Practice · 11.06.2026 · 43 (4)
DOI: 10.1093/fampra/cmag046 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Family Practice, online erschienen am 25.06.2026. Verfasst von Matthieu Fischer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Simone Veil Faculty of Medicine, University of Versailles Saint-Quentin-en-Yvelines (UVSQ), 78180 Montigny-le-Bretonneux, France. Hauptthemen laut MEDLINE: Musculoskeletal Diseases, Primary Health Care, Physical Therapy Modalities, Health Services Accessibility. Die Arbeit nennt 40 Literaturangaben.
Abstract (Originalsprache)
Background
Direct access (DA) to physiotherapy enables patients with musculoskeletal disorders (MSDs) to consult physiotherapists without prior GP referral. Despite its growing implementation, no quantitative synthesis has assessed its impact on prescribing outcomes relevant to GP workload.
Objective
To estimate the pooled effect of DA versus GP-led care on medication and imaging prescriptions for adults with MSDs in primary care.
Methods
This PRISMA-compliant meta-analysis, based on a registered review (OSF: 897ub), searched MEDLINE, Embase, CINAHL, Cochrane Library, and PEDro up to November 2025. Eligible studies compared DA with GP-referred care and reported medication and/or imaging prescriptions. Risk ratios (RRs) were pooled using random-effects models; shared-comparator correlation was managed by combining relevant arms, with sensitivity analyses examining them separately.
Results
Four studies (2993 participants) contributed to medication outcomes. Compared with GP-led pathways, DA was associated with fewer medication prescriptions (RR 0.57, 95% CI 0.40–0.83, I2 60%; sensitivity: RR 0.56, 95% CI 0.43–0.73, I2 45%; GRADE: low certainty). Evidence for imaging was insufficient. The planned X-ray-only analysis was uninformative due to sparse, zero-event data. A multi-modality sensitivity analysis suggested reduced imaging but without statistical significance (RR 0.48, 95% CI 0.16–1.41; very low certainty).
Conclusion
DA may reduce medication prescribing in MSDs, though evidence certainty remains low. Imaging results are inconclusive. Further high-quality, adequately powered trials with prespecified prescribing and imaging endpoints are warranted to guide equitable primary care workforce planning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Simone Veil Faculty of Medicine, University of Versailles Saint-Quentin-en-Yvelines (UVSQ), 78180 Montigny-le-Bretonneux, France.
- Jacques Prévert University Multiprofessional Health Centre (MSPU), 78180 Montigny-le-Bretonneux, France.
- Translational Innovation in Medicine and Complexity Laboratory (TIMC, U MR 5525), Grenoble Alpes University, 38000 Grenoble, France.
- Centre for Research in Epidemiology and Population Health (CESP), Inserm U1018, Université Paris-Saclay, UVSQ, Paul Brousse Hospital, 94800 Villejuif, France.
ORCID-Profile: Matthieu Fischer
Zitieren
APA
Fischer, M., Bui, E., Besombes, L., Pinsault, N., & François, M. (2026). Effect of direct access to physiotherapy on prescribing and imaging in primary care for musculoskeletal disorders: a systematic review and meta-analysis. Family Practice, 43(4). https://doi.org/10.1093/fampra/cmag046
Vancouver
Fischer M, Bui E, Besombes L, Pinsault N, François M. Effect of direct access to physiotherapy on prescribing and imaging in primary care for musculoskeletal disorders: a systematic review and meta-analysis. Family Practice. 2026;43(4). doi:10.1093/fampra/cmag046
BibTeX
@article{Fischer2026,
author = {Fischer, Matthieu and Bui, Emilie and Besombes, Laure and Pinsault, Nicolas and François, Mathilde},
title = {Effect of direct access to physiotherapy on prescribing and imaging in primary care for musculoskeletal disorders: a systematic review and meta-analysis},
journal = {Family Practice},
year = {2026},
volume = {43},
number = {4},
doi = {10.1093/fampra/cmag046}
}
EUVIMED